Joseph Montecalvo

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

Marina K. Baine, Min‐Shu Hsieh, W. Victoria Lai et al. · Journal of Thoracic Oncology · 2020 · 468 citations · Full text

Immunogenetics, Sclc Subtypes, Histopathologic Characterization +10

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

Alexander Drilon, Natasha Rekhtman, Maria E. Arcila et al. · The Lancet Oncology · 2016 · 462 citations · Full text

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Joshua K. Sabari, Giulia C. Leonardi, Catherine A. Shu et al. · Annals of Oncology · 2018 · 315 citations · Full text

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Natasha Rekhtman, Joseph Montecalvo, Jason C. Chang et al. · Journal of Thoracic Oncology · 2019 · 292 citations · Full text

Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis

Takashi Eguchi, Koji Kameda, Shaohua Lu et al. · Journal of Thoracic Oncology · 2018 · 270 citations

Surgical Oncology, Interventional Pulmonology, Advanced Lung Disease +10